Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from Quantum Biopharma ( (TSE:QNTM) ) is now available.
Quantum BioPharma Ltd. has announced its approval to dual list its shares on Upstream, a MERJ Exchange market, which will allow it to reach a global investor base outside of the U.S. This move aims to enhance liquidity and price discovery for its shares, offering a new investment channel for international investors. The dual listing is expected to globalize investment opportunities and streamline the trading process for existing non-U.S. shareholders.
More about Quantum Biopharma
Quantum BioPharma Ltd. operates in the biopharmaceutical industry, focusing on the development and commercialization of pharmaceutical products. The company is listed on multiple exchanges, including NASDAQ, CSE, and FRA, indicating a broad market focus.
YTD Price Performance: -5.88%
Average Trading Volume: 133,876
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $7.5M
For a thorough assessment of QNTM stock, go to TipRanks’ Stock Analysis page.
